PTCT files 8-K — PTC THERAPEUTICS, INC.
Regulation
PTC Therapeutics (PTCT) filed an 8-K with the SEC, indicating a material event has occurred. Without specific details on the 8-K's content, the market often reacts with uncertainty or speculation, creating a potential volatility play.
0 reads·0 theses
Angle
↑ LONG+10% target-5% stoptactical / 1 week
Go long PTCT on the dip following the unspecified 8-K filing, targeting a 10% rebound as details emerge.